|
Category
|
Patients number (%)
|
|---|
|
Menopausal status
| |
|
Premenopausal
|
115 (28.4)
|
|
Postmenopausal
|
290 (71.6)
|
|
Performance status (ECOG)
| |
|
0
|
379 (93.6)
|
|
1
|
22 (5.4)
|
|
2
|
4 (1.0)
|
|
Type of surgery
| |
|
Tumorectomy
|
173 (42.7)
|
|
Quadrantectomy
|
83 (20.5)
|
|
Mastectomy
|
149 (36.8)
|
|
Sentinel lymph-node biopsy
| |
|
No
|
157 (38.8)
|
|
Yes
|
248 (61.2)
|
|
Histological subtype
| |
|
Pure lobular
|
290 (71.6)
|
|
Ductal-lobular
|
105 (25.9)
|
|
Others
|
10 (2.5)
|
|
T descriptor according to TNM [7° Edition]
| |
|
1
|
233 (57.5)
|
|
2
|
128 (31.6)
|
|
3
|
31 (7.7)
|
|
4
|
11 (2.7)
|
|
Lymph-node status
| |
|
Negative
|
234 (57.8)
|
|
Positive
|
155 (38.2)
|
|
Unknown
|
16 (4.0)
|
|
Estrogen receptor status
| |
|
Negative
|
12 (3.0)
|
|
Positive
|
379 (93.6)
|
|
Unknown
|
14 (3.4)
|
|
Progesterone receptor status
| |
|
Negative
|
40 (9.9)
|
|
Positive
|
335 (82.7)
|
|
Unknown
|
30 (7.4)
|
|
HER2 status
| |
|
Negative
|
259 (64.0)
|
|
Positive
|
20 (4.9)
|
|
Unknown
|
126 (31.1)
|
|
Histological grade
| |
|
1
|
67 (16.5)
|
|
2
|
155 (38.3)
|
|
3
|
56 (13.8)
|
|
Unknown
|
127 (31.4)
|
|
Vascular invasion
| |
|
Absent
|
211 (52.1)
|
|
Present
|
84 (20.7)
|
|
Unknown
|
110 (27.2)
|
|
Multifocality
| |
|
Absent
|
316 (78.0)
|
|
Present
|
83 (20.5)
|
|
Unknown
|
6 (1.5)
|
|
Adjuvant hormonotherapy
| |
|
No
|
59 (14.6)
|
|
Yes
|
346 (85.4)
|
|
Adjuvant chemotherapy
| |
|
No
|
245 (60.5)
|
|
Yes
|
160 (39.5)
|
|
Adjuvant radiotherapy
| |
|
No
|
132 (32.6)
|
|
Yes
|
259 (64.0)
|
|
Unknown
|
14 (3.4)
|
- Legend – Table 1: ECOG Eastern Cooperative Oncology Group
